HBVZ10,一种基于AAV8载体的新型HBV治疗候选人,用于消除ccccDNA
Bai-Hua Zhang1, Yuanping Zhou2, Stephen Horrigan3
1Virology, HBVtech, Rockville, MD, USA.
Molecular therapy. Methods & clinical development
|December 17, 2025
概括
基因疗法HBVZ10阻断了新的乙型肝炎病毒 (HBV) 感染,有助于共价封闭圆形DNA (cccDNA) 消除. 在临床前研究中,将HBVZ10与恩特卡维尔结合使用显著降低了HBV标志物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因治疗 基因治疗
- 病毒学 病毒学
背景情况:
- 乙型肝炎病毒 (HBV) 的共价封闭圆形DNA (cccDNA) 消除是一个重要的治疗挑战.
- 肝炎病毒治疗失败与突变的肝炎病毒种群和通过新感染的补充有关.
- 阻止新的感染对于有限的HBV治疗方案至关重要.
研究的目的:
- 开发一种基因治疗候选物,HBVZ10,用于持续抑制新的HBV感染.
- 在临床前模型中评估HBVZ10在减少HBVccDNA和病毒标记物的疗效.
主要方法:
- 开发HBVZ10使用优化的腺相关病毒 (AAV) 载体8传递抗HBs抗体基因.
- 给uPA/SCID仿真小鼠注射HBVZ10以评估基因表达和治疗功能.
- 结合HBVZ10与细胞内复制抑制剂恩特卡维尔,以产生协同效应.
主要成果:
- 在单剂后200多天内,HBVZ10实现了持续高水平的抗HBs抗体表达 (≥100,000 mIU/mL).
- 结合HBVZ10和恩特卡维尔的联合治疗在几个月内导致ccccDNA减少了100倍以上.
- 血清HBeAg和HBsAg水平在组合治疗中逐渐降低到无法检测的水平.
结论:
- HBVZ10 证明了临床前的有效性,作为一种新的B型肝炎基因疗法.
- 阻止新的HBV感染是消除ccccDNA的可行策略.
- 这种方法支持向有限的HBV治疗方案的范式转变.
更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.1K
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
5.1K
相关概念视频
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...